Arvind Tewari

Arvind Tewari, MBiochem joined atai Life Sciences in 2021.

Previously, Arvind was Chief Operating Officer and acting Chief Executive Officer at Oxford VR where he was responsible for strategy, product development and clinical trial and commercial implementation.

Prior to that he was an Investment Manager at Epiris Private Equity where he was responsible for the due diligence, execution, portfolio management and digital transformation of buy-out investments into private companies of £100m – £500m in valuation.

Arvind holds a Bachelor and Master’s degree in Molecular and Cellular Biochemistry from the University of Oxford.